Inventor

Martin S. Linsell

Inventor
San Mateo, CA, US

Overview

76→
Patents
2000–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 76 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides20%
C07DHeterocyclic compounds9%
C07HSugars7%
B82YSpecific uses or applications of nanostructures5%
Y02ATechnologies for adaptation to climate change4%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C08LCompositions of macromolecular compounds1%
PatentTitleYear
11,117,915Antibacterial aminoglycoside analogs202111,071,771Butyrylcholinesterase zwitterionic polymer conjugates202110,702,608Factor VIII zwitterionic polymer conjugates2020RE047741Antibacterial aminoglycoside analogs201910,363,290Butyrylcholinesterase zwitterionic polymer conjugates20199,701,622'Antibacterial agents'20179,688,711'Antibacterial aminoglycoside analogs'20179,403,758'Antibacterial agents'20169,266,919'Antibacterial aminoglycoside analogs'20168,822,424'Antibacterial aminoglycoside analogs'20148,658,606'Antibacterial aminoglycoside analogs'20148,653,042'Antibacterial aminoglycoside analogs'20148,653,041'Antibacterial aminoglycoside analogs'20148,524,675'Antibacterial aminoglycoside analogs'20138,524,689'Antibacterial aminoglycoside analogs'20138,492,354'Antibacterial aminoglycoside analogs'20138,481,502'Antibacterial aminoglycoside analogs'20138,399,419'Antibacterial aminoglycoside analogs'20138,383,596'Antibacterial aminoglycoside analogs'20138,372,813'Antibacterial aminoglycoside analogs'20138,367,625'Antibacterial aminoglycoside analogs'20138,318,685'Antibacterial aminoglycoside analogs'20128,314,217'Cross-linked glycopeptide-cephalosporin antibiotics'20128,093,354'Process for preparing glycopeptide phosphonate derivatives'20128,084,417'Cross-linked glycopeptide-cephalosporin antibiotics'20117,964,730'Amino-substituted ethylamino β2 adrenergic receptor agonists'20117,871,997'Cephalosporin compounds'20117,728,104'Process for preparing glycopeptide phosphonate derivatives'20107,728,127'Cross-linked glycopeptide-cephalosporin antibiotics'20107,723,470'Glycopeptide derivatives and pharmaceutical compositions containing the same'20107,713,931'Cross-linked glycopeptide-cephalosporin antibiotics'20107,655,621'Cross-linked glycopeptide-cephalosporin antibiotics'20107,649,080'Cross-linked glycopeptide-cephalosporin antibiotics'20107,612,037'Cross-linked glycopeptide-cephalosporin antibiotics'20097,601,690'Cross-linked glycopeptide-cephalosporin antibiotics'20097,566,785'Amidine substituted aryl aniline compounds'20097,553,962'Cross-linked glycopeptide-cephalosporin antibiotics'20097,405,199'Cross-linked glycopeptide-cephalosporin antibiotics'20087,402,673'Diamine β2 adrenergic receptor agonists'20087,399,863'Amino-substituted ethylamino β2 adrenergic receptor agonists'20087,351,691'Glycopeptide phosphonate derivatives'20087,351,791'Intermediate for preparing glycopeptide derivatives'20087,341,993'Cross-linked glycopeptide—cephalosporin antibiotics'20087,332,471'Cross-linked glycopeptide-cephalosporin antibiotics'20087,301,004'Process for preparing glycopeptide phosphonate derivatives'20077,279,458'Cross-linked glycopeptide-cephalosporin antibiotics'20077,265,086'Glycopeptide carboxy-saccharide derivatives'20077,244,705'Polyacid glycopeptide derivatives'20077,157,554'Glycopeptide carboxy-saccharide derivatives'20077,101,964'Intermediate for preparing glycopeptide derivatives'20067,074,890'Process for preparing glycopeptide phosphonate derivatives'20067,074,760'Polyacid glycopeptide derivatives'20067,067,482'Cross-linked glycopeptide-cephalosporin antibiotics'20067,067,481'Cross-linked glycopeptide-cephalosporin antibiotics'20067,067,620'Antibacterial agents'20067,008,923'Glycopeptide phosphonate derivatives'20066,995,138'Cross-linked glycopeptide-cephalosporin antibiotics'20066,979,723'Process for preparing glycopeptide phosphonate derivatives'20056,974,797'Cross-linked glycopeptide-cephalosporin antibiotics'20056,962,970'Glycopeptide derivatives and pharmaceutical compositions containing the same'20056,949,681'Intermediate for preparing glycopeptide derivatives'20056,906,031'Polyacid glycopeptide derivatives'20056,903,070'Glycopeptide carboxy-saccharide derivatives'20056,887,976'Glycopeptide phosphonate derivatives'20056,878,686'Cross-linked glycopeptide-cephalosporin antibiotics'20056,872,701'Glycopeptide phosphonate derivatives'20056,831,150'Reductive alkylation process'20046,770,621'Polyacid glycopeptide derivatives'20046,635,618'Glycopeptide phosphonate derivatives'20036,620,781'Glycopeptide carboxy-saccharide derivatives'20036,562,854'Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders'20036,518,242'Derivatives of glycopeptide antibacterial agents'20036,455,669'Glycopeptide derivatives and pharmaceutical compositions containing the same'20026,444,786'Glycopeptide derivatives and pharmaceutical compositions containing the same'20026,392,012'Glycopeptide derivatives and pharmaceutical compositions containing the same'20026,150,379'Compounds and compositions as anticoagulants'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2021Based in San Mateo, CA, US· patent location history
2002–2012Patents assigned to THERAVANCE INC (50)· patent assignee history
2003Based in Foster City, CA, US· patent location history
2005–2011Based in San Francisco, CA, US· patent location history
2012–2019Patents assigned to ACHAOGEN INC (18)· patent assignee history
2012–2014Patents assigned to AGGEN JAMES BRADLEY (11)· patent assignee history
2012–2014Patents assigned to DOZZO PAOLA (11)· patent assignee history
2012–2014Patents assigned to GOLDBLUM ADAM AARON (11)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
THERAVANCE INC502002–2012
ACHAOGEN INC182012–2019
AGGEN JAMES BRADLEY112012–2014
DOZZO PAOLA112012–2014
GOLDBLUM ADAM AARON112012–2014
Locations
LocationPatentsSpan
San Mateo, California, US632000–2021
San Francisco, California, US122005–2011
Foster City, California, US12003